PDI Inhibition Enhances Panobinostat Efficacy in Myeloma Mod
2026-05-06
This study demonstrates that combining the PDI inhibitor LTI6426 with panobinostat significantly enhances anti-myeloma activity in both in vitro and in vivo models, even in proteasome inhibitor-resistant settings. The findings highlight a promising regimen that may allow for lower panobinostat doses, potentially reducing toxicity and improving tolerability in multiple myeloma therapy.
Entinostat (MS-275): Precision HDAC1/3 Inhibition in Cancer
2026-05-05
Entinostat (MS-275) enables highly selective, reproducible inhibition of HDAC1 and HDAC3 in cancer research, empowering both anti-proliferative and apoptosis-inducing studies. This guide provides optimized workflows, troubleshooting, and practical translation of recent in vitro advances to maximize reliability in oncology experiments.
Merimepodib (VX-497): Reliable IMPDH Inhibition in Lab Assay
2026-05-05
Advance reproducibility in cytotoxicity, proliferation, and antiviral assays with Merimepodib (VX-497) (SKU B1112). This evidence-based guide addresses workflow pitfalls, protocol optimization, and vendor selection—supporting researchers seeking data-backed, selective IMPDH inhibition for cancer, immunology, and virology applications.
Aconitase Activity Colorimetric Assay Kit: Optimizing TCA Cy
2026-05-04
The Aconitase Activity Colorimetric Assay Kit enables precise, high-throughput quantification of the iron-sulfur protein aconitase, vital for probing mitochondrial metabolism and oxidative stress in research. This article details best-practice workflows, troubleshooting, and advanced applications, bridging cutting-edge immunometabolic insights with robust assay execution.
Tacalcitol Monohydrate Enhances 5-FU Efficacy in Colorectal
2026-05-04
This article reviews research demonstrating that tacalcitol monohydrate, a synthetic analog of vitamin D3, enhances the anticancer activity of 5-fluorouracil in colorectal cancer models by downregulating thymidylate synthase via VDR-dependent pathways. The findings suggest mechanistic insight and translational value for combining vitamin D analogs with standard chemotherapy.
Perospirone Inhibits Kv1.5 Channels in Coronary Arterial Myo
2026-05-03
A recent study reveals that Perospirone, an atypical antipsychotic, directly inhibits vascular Kv1.5 channels in coronary arterial smooth muscle cells, independent of its classical serotonergic and dopaminergic receptor actions. This off-target effect broadens the pharmacological understanding of Perospirone and highlights new cardiovascular considerations for researchers.
U-73122: Advanced Phospholipase C Inhibitor for Signal Modul
2026-05-02
U-73122 stands out as a potent phospholipase C inhibitor, enabling precise dissection of PLC-driven signaling pathways in cancer, inflammation, and calcium flux assays. With validated protocols and troubleshooting strategies, researchers can confidently apply U-73122 to unravel complex cellular mechanisms and support translational breakthroughs.
Dissecting In Vitro Drug Responses: Insights from Viability
2026-05-02
Schwartz's dissertation redefines how in vitro drug responses in cancer are interpreted by distinguishing between relative and fractional viability metrics. The work demonstrates that these metrics capture distinct effects of anti-cancer agents, offering a clearer framework for evaluating proliferation and cell death in preclinical research.
Haloprogin: Broad-Spectrum Activity Against Dermatophytes an
2026-05-01
This article analyzes the pivotal 1970 study that established Haloprogin as a potent topical antifungal with a unique spectrum of activity, including efficacy against dermatophytes, Candida species, and selective Gram-positive bacteria. The findings are dissected for their methodological rigor and enduring translational relevance in infection research models.
Oseltamivir Acid: Advanced Influenza Neuraminidase Inhibitor
2026-04-30
Oseltamivir acid, the active metabolite of a gold-standard influenza neuraminidase inhibitor, is revolutionizing both antiviral and oncology research through its robust, reproducible inhibition of viral propagation and tumor metastasis. Explore optimized experimental workflows, troubleshooting strategies, and the translational impact of recent prodrug research—powered by APExBIO’s rigorously validated compound.
Puromycin dihydrochloride: Precision Selection and Translati
2026-04-30
Puromycin dihydrochloride stands as a gold-standard aminonucleoside antibiotic for precise selection of pac gene-expressing cell lines and advanced translational research. This article provides step-by-step protocols, troubleshooting strategies, and real-world assay enhancements, leveraging APExBIO’s trusted reagent quality for robust, reproducible results.
Refining In Vitro Drug Response Metrics in Cancer Research
2026-04-29
Schwartz’s dissertation advances the evaluation of anti-cancer drugs by distinguishing and rigorously quantifying cell proliferation arrest versus cell death using refined in vitro metrics. These insights enable more precise preclinical assessment of targeted therapies, with practical implications for optimizing drug screening and translational oncology pipelines.
One-step TUNEL Cy3 Apoptosis Detection Kit: Precision in DNA
2026-04-29
The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines fluorescent apoptosis detection in both tissue sections and cultured cells, enabling rapid, high-sensitivity analysis of DNA fragmentation. Its robust performance and protocol flexibility set a new standard for apoptosis research workflows.
Defining Human Skeletal Myogenic Lineages in PSC-Derived Ter
2026-04-28
This study establishes a robust approach for generating and characterizing skeletal myogenic progenitors from human pluripotent stem cell (PSC)-derived teratomas. By leveraging single-cell transcriptomics and novel surface markers, the research advances isolation strategies for regenerative medicine and muscle disease modeling.
BX795: Strategic PDK1 Inhibition for Translational Discovery
2026-04-28
Explore how BX795, a potent and selective PDK1 inhibitor, empowers translational researchers to dissect complex cancer and immune signaling networks. This thought-leadership piece bridges mechanistic depth with actionable strategy, drawing on recent methodological advances in in vitro drug evaluation and competitive kinase inhibitor research.
464 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page